Document Detail


Management of pregnant women with mechanical heart valve prosthesis: thromboprophylaxis with low molecular weight heparin.
MedLine Citation:
PMID:  19162303     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
INTRODUCTION: Pregnancy increases the risk of mechanical heart valve (MHV) thrombosis. Warfarin is protective, but implies risks to the fetus. Unfractionated heparin (UFH) is less effective but does not harm the fetus. In general, anticoagulation is more stable and predictable with low molecular weight heparin (LMWH) than with UFH. METHOD: Retrospective study of 12 pregnancies with MHV; 6 in aortic, 4 in mitral, and 2 in both positions, treated with therapeutic doses of subcutaneous LMWH twice daily throughout pregnancy. Doses were adjusted using anti-Xa monitoring. The frequency of thrombo-embolism with various anticoagulation regimes was calculated based on a literature review. RESULTS: Median LMWH dose was 15500 IU/24 h, range 10000-20000 IU/24 h; median dose 257 IU/kg/24 h. Median peak LMWH in blood plasma ranged 0.54-0.92 anti-Xa U/mL. Thromboembolism developed in two women with aortic MHV despite LMWH levels in target range. One had systemic embolic episodes; in the other woman valve thrombosis was successfully thrombolysed. Both had initially received subtherapeutic doses. Thrombo-embolism was not observed in ten pregnancies treated as recommended. The pregnancies resulted in thirteen healthy babies; eight delivered by Cesarean section. Bleeding occurred in two women after Cesarean section due to preeclampsia. CONCLUSION: Treatment with adjusted therapeutic doses of LMWH was successful in 10 of 12 pregnancies, and was not associated with fetal complications. Thromboembolism occurred in two pregnancies, possibly attributed to subtherapeutic doses of LMWH during the initial 3 weeks. Compared to UFH prophylaxis, therapeutic doses of LMWH appears to be more efficacious.
Authors:
Ulrich Abildgaard; Per Morten Sandset; Jens Hammerstrøm; Finn Tore Gjestvang; Arnljot Tveit
Related Documents :
10377303 - Anticoagulation in pregnant women with mechanical heart valve prostheses.
2365123 - Thrombosis in a mechanical aortic valve prosthesis during subcutaneous heparin therapy ...
15884773 - Birth of rhesus macaque (macaca mulatta) infants after in vitro fertilization and gesta...
Publication Detail:
Type:  Journal Article     Date:  2009-01-21
Journal Detail:
Title:  Thrombosis research     Volume:  124     ISSN:  1879-2472     ISO Abbreviation:  Thromb. Res.     Publication Date:  2009 Jul 
Date Detail:
Created Date:  2009-07-14     Completed Date:  2009-09-30     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0326377     Medline TA:  Thromb Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  262-7     Citation Subset:  IM    
Affiliation:
Department of Hematology, Aker University Hospital, Oslo, Norway. ulrich.abildgaard@medisin.uio.no
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Anticoagulants / administration & dosage
Female
Heart Valve Prosthesis / adverse effects*
Heparin, Low-Molecular-Weight / administration & dosage*
Humans
Pregnancy
Pregnancy Complications, Cardiovascular / prevention & control*
Retrospective Studies
Thrombosis / etiology*,  prevention & control*
Treatment Outcome
Chemical
Reg. No./Substance:
0/Anticoagulants; 0/Heparin, Low-Molecular-Weight

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cold surge: a sudden and spatially varying threat to health?
Next Document:  Circulating tissue factor procoagulant activity is elevated in stable moderate to severe chronic obs...